Search results
£500 million
- £500 million (no change) South African-born Tabatznik, 70, sold his Stevenage business Arrow Generics to US firm Watson Pharmaceuticals for $1.75 billion. He had previously netted £200 million for his family’s Generics (UK) outfit.
businesstech.co.za/news/wealth/244439/meet-the-ultra-rich-south-africans-youve-probably-never-heard-of/Meet the ultra-rich South Africans you’ve probably never heard of
May 13, 2019 · South African-born Tabatznik sold his Stevenage business Arrow Generics to US firm Watson Pharmaceuticals for $1.75 billion. He had previously netted £200 million for his family’s Generics (UK...
May 14, 2018 · South African-born Tabatznik, 70, sold his Stevenage business Arrow Generics to US firm Watson Pharmaceuticals for $1.75 billion. He had previously netted £200 million for his family’s Generics...
May 14, 2019 · 268: Tony Tabatznik. Net worth: £500 million / R9.3 billion. Business: Pharmaceutical products. UK connection: Operated a British company until a $1.75 billion buyout from the US, lives...
Jul 11, 2021 · Steyn has seen his net worth climb by a staggering £1.1 billion (R21.7 billion) over the last year, according to the paper, taking his value up to an estimated £2.05 billion (R40.4 billion).
Apr 15, 2021 · Tony Tabatznik ran his family’s business, Stevenage firm Arrow Generics, which specialises in sterile products and respiratory drugs. The family struck gold when he sold Arrow Generics for R25 billion to a US drug company in 2009.
268: Tony Tabatznik and Family – South African-born Tabatznik, 70, sold his Stevenage business Arrow Generics to US firm Watson Pharmaceuticals for $1.75 billion. He had previously netted £200 million for his family’s Generics (UK) outfit.
Tshemba’s lead founder, Neil Tabatznik, was approached by the tracker of the drive to help with the slow build of his daughter’s satellite primary school. Neil agreed to build the entire school, but still wanted to do more.
